Inventor

SEXTON DANIEL J

US43 patents

⚠️ This page may combine multiple inventors who share the name “SEXTON DANIEL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SEXTON DANIEL J

TAKEDA PHARMACEUTICALS CO

Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema

Methods of detecting plasma kallikrein

Nucleic acids encoding plasma kallikrein binding proteins

Assays for determining plasma kallikrein system biomarkers

Metabolite biomarkers for diseases associated with the contact activation system

Compositions and methods for treatment of diabetic macular edema

Diagnosis and treatment of autoimmune diseases

Antibodies which bind Fc receptors (FcRn)

Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation

Methods of determining levels of cleaved and/or intact kininogen

Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK

Plasma kallikrein binding proteins

Nucleic acids encoding FcRn-binding antibodies, pharmaceutical compositions thereof and methods of use thereof to make antibodies

Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation

Assays for determining plasma kallikrein system biomarkers

Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema

Cleaved high molecule weight kininogen (HMWK) antibodies and methods of using

Monoclonal antibody inhibitor of Factor XIIa

Metabolite biomarkers for diseases associated with the contact activation system

RNA biomarkers for hereditary angioedema

Protein biomarkers for diseases associated with the contact activation system

Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK

DYAX CORP

Plasma kallikrein binding proteins

Method of treating hereditary angioedema using plasma kallikrein binding antibodies

Antibodies that bind hK-1

Compositions and methods for treatment of diabetic macular edema

Methods of inhibiting plasma kallikrein in edema patient

Compositions and methods for treatment of diabetic macular edema

Fc receptor antibodies and methods of use thereof

Methods of producing antibodies to neonatal Fc receptor (FcRn)

Diagnosis and treatment of autoimmune diseases

Diagnosis and treatment of autoimmune diseases

Immunoassay to detect cleaved high molecular weight kininogen

HK1-binding proteins

Nucleic acids encoding anti-neonatal Fc receptor (FcRn) antibodies

Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation

Monoclonal antibody inhibitor of factor XIIA

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

SEXTON DANIEL J

Plasma kallikrein binding proteins

Plasma kallikrein binding proteins

Human neonatal Fc receptor antibodies and methods of use thereof

SATO AARON K

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy